Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patien… (NCT05275218) | Clinical Trial Compass
RecruitingNot Applicable
Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery
Germany480 participantsStarted 2023-03-22
Plain-language summary
There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury.
To investigate whether an implementation of a supportive extended care "bundle" in high-risk patients for persistent acute kidney injury (AKI) can reduce the occurrence of persistent surgical AKI.
In order to investigate whether the extended KDIGO bundle can prevent persistent AKI in patients with high chemokine ligand 14 (CCL14) as well as in patients with low CCL14, patients will be randomized with stratification by the CCL-value.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Adult patients (age ≥18 years)
✓. Moderate or severe AKI ((defined by the 2012 KDIGO criteria, KDIGO stage 2 and 3), determined by either serum creatinine or urine output) within 72h after a surgical procedure
✓. Written informed consent
Exclusion criteria
✕. Dialysis-dependent chronic kidney disease
✕. Prior kidney transplant
✕. Infections with human immunodeficiency virus or hepatitis
✕. Hepatorenal syndrome
✕. Pregnancy or breast-feeding
✕. Participation in another interventional trial that investigates a drug that affects the kidney function within the last 3 months
✕. Persons held in an institution by legal or official order